Further, by clarifying the specific pathway of LCN2 in cerebral ischemia/reperfusion injury, we can help to develop more targeted therapeutic drugs with fewer side effects and optimize the clinical therapeutic regimen to improve the quality of patients’ survival and prognosis. Here, LCN2 is linked to brain ischemia.